Sarah Hassan

Sarah Hassan
As an associate for the healthcare advisory team, Sarah's areas of focus include digital health and the changing regulatory dynamics of the US healthcare system. Prior to joining Eurasia Group, Sarah was an advisory associate at PricewaterhouseCoopers, where she helped regulated industry clients such as pharmaceutical firms manage their information systems. She earned a bachelor's degree in finance from the University of Pennsylvania, The Wharton School. At Eurasia Group, Sarah enjoys developing new projects with colleagues from other teams; she credits her knack for this kind of work to having a large family. Sarah has 70+ first cousins with a …
As an associate for the healthcare advisory team, Sarah's areas of focus include digital health and the changing regulatory dynamics of the US healthcare system.

Prior to joining Eurasia Group, Sarah was an advisory associate at PricewaterhouseCoopers, where she helped regulated industry clients such as pharmaceutical firms manage their information systems. She earned a bachelor's degree in finance from the University of Pennsylvania, The Wharton School.

At Eurasia Group, Sarah enjoys developing new projects with colleagues from other teams; she credits her knack for this kind of work to having a large family. Sarah has 70+ first cousins with a new one on the way this year.
See more

Articles: Sarah Hassan

The Three Top Political Issues for Big Pharma

Opinion / Eurasia Group’s Aditya Bhattacharji and Sarah Hassan identify and unpack the top three political and policy issues that multinational pharmaceutical firms are currently focusing on.   Issue One: The Global Economy Over the past month, one theme stood out at both the central bankers’ confab in Jackson Hole, Wyoming and the G7 summit in Biarritz,…

See more